These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 450301)

  • 1. [Behavior of IRI and some blood lipid indices after buformin administration].
    Quartarone M; Saitta A; Caruso G; Monacciani U; Perdichizzi G; Squadrito G
    Minerva Med; 1979 May; 70(22):1623-8. PubMed ID: 450301
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
    Ohara S; Komatsu R; Matsuyama T
    Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood sugar, insulin, and blood lipid disorders after oral administration of glucose and medium-chain triglycerides in diabetics].
    Ferlito S; Lo Furno F; Munaò F; Lunetta M
    Minerva Dietol Gastroenterol; 1978; 24(1):33-42. PubMed ID: 740266
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of a clinical study of a group of hospitalized diabetics under treatment with depot buformin].
    Durante F; Scaffidi A; Rotolo G; Rini GB
    Minerva Med; 1978 May; 69(24):1665-72. PubMed ID: 662170
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma-insulin response to glucose and circulating serum lipid levels in first-degree relatives of diabetic patients.
    Jakobson T
    Ann Clin Res; 1972 Apr; 4(2):70-7. PubMed ID: 5028067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Follow-up study on the effects of buformin on the serum vitamin B-12 level and on the motility of the stomach and small intestine in diabetics].
    Brunová E; Slabochová Z; Hrubá F; Nováková V; Bejblová O; Vondra K
    Vnitr Lek; 1978 Mar; 24(3):277-81. PubMed ID: 644896
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of Buformin retard in adipose patients with impaired glucose tolerance].
    Schräpler P; Schulz E; Adlung J
    Med Welt; 1975 Oct; 26(42):1919-21. PubMed ID: 1186481
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid changes after fasting in obese patients].
    Schrub JC; Joly JP; Wolf LM; Courtois H; Matray P; Rousseau PY; Brunelle P
    Sem Hop; 1973 Apr; 49(19):1349-56. PubMed ID: 4355381
    [No Abstract]   [Full Text] [Related]  

  • 9. [Buformin-influenced calcium absorption (author's transl)].
    Brunová E; Kocián J; Slabochová Z; Vondra K
    Cas Lek Cesk; 1979 Aug; 118(31):975-8. PubMed ID: 526987
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum lipid levels in subjects with impaired glucose tolerance.
    Puavilai G; Tanphaichitr V; Banphotkasem S; Supitak V; Asawkul W; Sriphrapradaeng A
    J Med Assoc Thai; 1988 May; 71(5):262-8. PubMed ID: 3294328
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of the transplacental blastomogenic effect of N-nitrosomethylurea in rats by buformin].
    Anisimov VN; Aleksandrov VA; Belous NM; Vasil'eva IA; Matson VB
    Biull Eksp Biol Med; 1980 Jul; 89(7):88-90. PubMed ID: 6996759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigations of the mode action of buformin using a 3H-labelled glucose in people with a healthy metabolism (author's transl)].
    Bottermann P; Schweigart U; Ermler R
    Med Klin; 1976 Sep; 71(36):1423-8. PubMed ID: 958105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipids and immunoreactive insulin in relatives of diabetic patients.
    Jakobson T
    Isr J Med Sci; 1972 Jun; 8(6):831-2. PubMed ID: 5051810
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of HDL cholesterol in diabetes mellitus in relation to various types of therapy].
    Floriani M; Spadoni M
    Quad Sclavo Diagn; 1984 Jun; 20(2):236-43. PubMed ID: 6396678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some aspects of the dynamic behavior of IRI in obesity and in diabetes mellitus].
    Squadrito G
    Minerva Med; 1979 May; 70(23):1651-8. PubMed ID: 450305
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of long term sulfonylurea therapy on plasma insulin and fasting lipid levels.
    Podolsky S; Burney SW
    Diabete Metab; 1979 Jun; 5(2):113-7. PubMed ID: 478080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antagonistic action of prednisolone and buformin in the carbohydrate metabolism of healthy persons (author's transl)].
    Bottermann P; Schweigart U; Ermler R
    Med Klin; 1976 Feb; 71(7):275-80. PubMed ID: 815773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of IRI after carbohydrate and aminophylline stimulation in normal, obese and diabetic subjects].
    Quartarone M; Cucinotta D; Longo G; Coglitore G; Squadrito G
    Minerva Med; 1979 May; 70(22):1629-33. PubMed ID: 450302
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the therapy of diabetes mellitus with biguanides].
    Riess PJ; Saum R
    Med Klin; 1968 May; 63(19):764-7. PubMed ID: 5730198
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of long-term biguanide therapy as a preventive measure in protodiabetes].
    Neumann VI; Michaelis D; Schulz B; Wulfert P; Heinke P
    Endokrinologie; 1975 Feb; 64(3):290-8. PubMed ID: 1227826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.